We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.
Members of the Oxford and Thames Valley MDS Patient Support Group, which provides support to those affected by Myelodysplastic Syndromes, visited the MRC Weatherall Institute of Molecular Medicine (WIMM) on Friday 29 September. The visit was hosted by Dr Lynn Quek and members of Prof Paresh Vyas' research team at the MRC Molecular Hematology Unit, who are members of the Radcliffe Department of Medicine. Their research is supported by the NIHR Oxford Biomedical Research Centre.
